ETLI.DE
L&G Pharma Breakthrough UCITS ET
ETLI.DE
ETF Price
9,69
0,02 Bil. AUM
0,5% Expense Ratio
9,00 NAV
L&G Pharma Breakthrough UCITS ET Profile
About L&G Pharma Breakthrough UCITS ET
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
- Company
- Holdings
- 0
- CUSIP
L&G Pharma Breakthrough UCITS ET Sectors
Industry | Percentage |
---|---|
Healthcare | 100,00% |
Basic Materials | 0,00% |
Technology | 0,00% |
Real Estate | 0,00% |
Industrials | 0,00% |
Financial Servic | 0,00% |
Energy | 0,00% |
Consumer Defensi | 0,00% |
Consumer Cyclica | 0,00% |
Communication Se | 0,00% |
Utilities | 0,00% |